Inovio Pharmaceuticals, Inc. ( INO) - Stock Earnings
INO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
INO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 3.8 million USD | -65343 USD |
| 2026Q1 | -19.7 million USD | — USD |
| 2026Q2 | -6.0 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
INO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -135.1 million USD | 832010 USD |
| 2024 | -107.3 million USD | 217756 USD |
| 2025 | -84.9 million USD | 65343 USD |
| 2026 Est. | — | — |
INO
Price: $1.20
Earnings Per Share: -1.03 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.8 million
Ebitda: -28.0 millionMarket Capitalization: 112.6 million